Interleukin‐1 blockade in heart failure with preserved ejection fraction: rationale and design of the Diastolic Heart Failure Anakinra Response Trial 2 (D‐HART2)

Heart failure with preserved ejection fraction (HFpEF) now accounts for the majority of confirmed HF cases in the United States. However, there are no highly effective evidence‐based treatments currently available for these patients. Inflammation correlates positively with adverse outcomes in HF pat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clin Cardiol
Hauptverfasser: Van Tassell, Benjamin W., Buckley, Leo F., Carbone, Salvatore, Trankle, Cory R., Canada, Justin M., Dixon, Dave L., Abouzaki, Nayef, Oddi‐Erdle, Claudia, Biondi‐Zoccai, Giuseppe, Arena, Ross, Abbate, Antonio
Format: Artigo
Sprache:Inglês
Veröffentlicht: Wiley Periodicals, Inc. 2017
Schlagworte:
Trial Designs
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5744484/
https://ncbi.nlm.nih.gov/pubmed/28475816
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.22719
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge